Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia

Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia

Bibliographic Details
Main Authors:	Dennis, Mike, Davies, Michelle, Oliver, Stuart, D’Souza, Roy, Pike, Laura, Stockman, Paul
Format:	Online
Language:	English
Published:	Springer-Verlag 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428523/

Similar Items

Activity of the aurora kinase B inhibitor AZD1152 in acute myeloid leukaemia
by: Grundy, Martin
Published: (2012)

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)
by: Keizer, Ron J., et al.
Published: (2011)

P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the Aurora-B Kinase Inhibitor barasertib-hQPA
by: Grundy, Martin, et al.
Published: (2011)

Structure of Aurora B–INCENP in complex with barasertib reveals a potential transinhibitory mechanism
by: Sessa, Fabio, et al.
Published: (2014)

Barasertib: a novel approach for the treatment of metastatic melanoma
by: Azzariti, Amalia, et al.
Published: (2014)

Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma
by: Naing, A, et al.
Published: (2012)

Evaluation of the Pharmacokinetic Interaction between Lesogaberan (AZD3355) and Esomeprazole in Healthy Subjects
by: Niazi, Mohammad, et al.
Published: (2012)

The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression
by: Harada, Masako, et al.
Published: (2015)

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
by: Hartsink-Segers, S A, et al.
Published: (2013)

The Aurora Kinases in Cell Cycle and Leukemia
by: Goldenson, Benjamin, et al.
Published: (2014)

A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
by: Zhou, Liang, et al.
Published: (2014)

Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles
by: Baek, Miri, et al.
Published: (2012)

Pharmacokinetics, bioavailability, metabolism and excretion of δ-viniferin in rats
by: Mao, Ping, et al.
Published: (2016)

Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells
by: Kim, Soo-Jeong, et al.
Published: (2012)

Auroras migrantes = Auroras in migration
by: Cury, Maria Zilda Ferreira
Published: (2015-01-01)

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors
by: Esaki, Taito, et al.
Published: (2011)

Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects: A Novel GABAB-Receptor Agonist Reflux Inhibitor
by: Niazi, Mohammad, et al.
Published: (2012)

Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)
by: Bjermer, Leif, et al.
Published: (2015)

Discovery of AZD-2098 and AZD-1678, two potent and bioavailable CCR4 receptor antagonists
by: Kindon, Nicholas, et al.
Published: (2017)

The Advantage of a Total Knee Arthroplasty with Rotating Platform is Only Theoretical: Prospective Analysis of 1,152 Arthroplasties
by: Delport, H.P.
Published: (2013)

Retraction: Hydrogen Peroxide as an Effective Disinfectant for Pasteurella multocida. Yonsei Med J 2014;55:1152-6
by: Jung, In-Soo, et al.
Published: (2016)

Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib
by: Steeghs, Neeltje, et al.
Published: (2010)

AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells
by: Maenhout, Sarah K., et al.
Published: (2014)

AZD9291-induced Acute Interstitial Lung Disease
by: Nie, Ke-Ke, et al.
Published: (2016)

AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair
by: Ford, James B., et al.
Published: (2015)

Pharmacokinetics and Excretion Studies on CDRI-85/92, an Antiulcer Proton Pump Inhibitor
by: Srivastava, Pratima
Published: (2012)

Pharmacokinetics and Excretion of 14C-Bendamustine in Patients with Relapsed or Refractory Malignancy
by: Dubbelman, Anne-Charlotte, et al.
Published: (2013)

Pharmacokinetics, Tissue Distribution and Excretion of a Novel Diuretic (PU-48) in Rats
by: Zhi-Yuan Zhang, et al.
Published: (2018-08-01)

Pharmacokinetics and excretion of 14C-omacetaxine in patients with advanced solid tumors
by: Nijenhuis, Cynthia M., et al.
Published: (2016)

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment
by: Ouwerkerk-Mahadevan, Sivi, et al.
Published: (2015)

Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function
by: He, Ping, et al.
Published: (2014)

Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation
by: Wang, Le-Xun, et al.
Published: (2016)

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer’s disease patients
by: Forsberg, Anton, et al.
Published: (2013)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
by: Giallongo, Cesarina, et al.
Published: (2015)

MECHANISM OF UREA EXCRETION
by: Oliver, Jean
Published: (1921)

Myeloid leukemia after hematotoxins.
by: Larson, R A, et al.
Published: (1996)

Chronic myeloid leukemia in India
by: Goldman, John M.
Published: (2013)

Bosutinib for Chronic Myeloid Leukemia
by: Breccia, Massimo, et al.
Published: (2015)

Combining AZD8931, a novel EGFR/HER2/HER3 signalling inhibitor, with AZD5363 limits AKT inhibitor induced feedback and enhances antitumour efficacy in HER2-amplified breast cancer models
by: CRAFTER, CLAIRE, et al.
Published: (2015)

Aurora Metals
Published: (1998)